Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

Your blood pressure can reveal a lot about your health, from heart and kidney function to potential risks for diabetes, ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

Areas with elevated microplastic levels experience increased rates of hypertension, diabetes, stroke, and other ...

The primary outcome was the time to the first ischaemic or haemorrhagic stroke after diabetes diagnosis, with follow-up until death or December 31, 2022. "These findings highlight the need for ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

New research suggests areas with higher concentrations of microplastics also have higher rates of chronic disease.